Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT06355947
Other study ID # 103-7445B
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 7, 2015
Est. completion date July 31, 2018

Study information

Verified date April 2024
Source Chang Gung University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Motor impairment in lower extremities is common in individuals with Parkinson disease (PD). Development sensitive test for early motor deviations is important. Conventional walking test cannot induce the PD related motor impairments, such as freezing of gait. Therefore, finding a safe substitute test to induce PD related motor impairments is important. Studies showed that working memory related dual task walking was a sensitive test for PD. However, the optimal cognitive test needs to be clarified. Studies also showed that the neuromuscular control mechanism of leg movements during cycling were similar to those during walking. Therefore, dual task cycling test is potential to be a safe and sensitive testing model. Studies showed that exercise could improve cognitive function and induce brain plasticity. Dual task exercise training was shown to be more effective than single task exercise training for older people to prevent fall. Whether the added cognitive task could improve to detriment brain plasticity in PD should be investigated. Transcranial magnetic stimulation can evaluate the motor cortex plasticity on-invasively and can evaluate the exercise induced brain plasticity. The purpose of this three-year project is to develop PD-sensitive. The purposes of the first year are to translate the dual task walking test to dual task cycling test, and to establish the reliability of the dual task cycling test. The purposes of the second year are to compare the motor cortex plasticity induced by single task cycling versus dual task cycling and to compare the difference response between PD and healthy control people. The purpose of the third year is to evaluate the effect of 8 week long term cycling training or treadmill training of individuals with PD on motor cortex plasticity, dual task performance, and ambulation ability.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date July 31, 2018
Est. primary completion date September 11, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years and older
Eligibility Health subjects: Exclusion Criteria: - Musculoskeletal injuries on legs. - Osteoporosis. PD subjects: Inclusion Criteria: - Clinical diagnosis of Parkinson disease. Exclusion Criteria: - Musculoskeletal injuries on legs - Osteoporosis. - Any peripheral or central nervous system injury or disease patients.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cognitive cycling training
Cycling training conducted with cognitive tasks
Cognitive treadmill training
Treadmill training conducted with cognitive tasks

Locations

Country Name City State
Taiwan Chang Gung University Taoyuan

Sponsors (1)

Lead Sponsor Collaborator
Chang Gung University

Country where clinical trial is conducted

Taiwan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Walking Speed The time taken by participants to walk a standardized distance, typically expressed in centimeters per second (cm/s). Baseline, 4 weeks and 8 weeks
Primary Step Length The linear distance between the two ankles, typically expressed in centimeters(cm). Baseline, 4 weeks and 8 weeks
Primary Step Time The duration taken for one complete step, measuring from foot-off of one foot to the next foot-off of the same foot, usually expressed in seconds. Baseline, 4 weeks and 8 weeks
Primary Power Spectral Density (PSD) Quantifies the power of EEG signals within specific frequency bands (e.g., delta, theta, alpha, beta, and gamma) over a period. Baseline, 4 weeks and 8 weeks.
Primary Task Accuracy The percentage of correct responses or actions made by participants in response to walking or cycling tasks. Baseline, 4 weeks and 8 weeks.
Primary Reaction Time The duration between the onset of task start time and the participant's response to it, typically expressed in second (s). Baseline, 4 weeks and 8 weeks.
Primary Balance Performance Measured by the duration the stance can be maintained, typically expressed second. Baseline, 4 weeks and 8 weeks
Secondary Double Support Time The portion of the gait cycle where both feet are in contact with the ground, indicating the transition phase between steps, expressed as a percentage of the gait cycle or in seconds. Baseline, 4 weeks and 8 weeks
Secondary Single Support Time The duration within the gait cycle when only one foot is in contact with the ground, typically measured in seconds or as a percentage of the total gait cycle. Baseline, 4 weeks and 8 weeks
Secondary Swing Time The portion of the gait cycle where the foot is not in contact with the ground, moving forward to the next step. It is usually expressed as a percentage of the total gait cycle or in seconds. Baseline, 4 weeks and 8 weeks
Secondary Stance Time The portion of the gait cycle when the foot is in contact with the ground, supporting body weight. It's typically expressed as a percentage of the total gait cycle or in seconds Baseline, 4 weeks and 8 weeks
Secondary Cadence The number of steps an individual takes per minute, providing an overview of gait speed and rhythm, , expressed as steps per minute. Baseline, 4 weeks and 8 weeks
Secondary Heart rate The number of heartbeats per minute on resting, walking or cycling tasks. Baseline
See also
  Status Clinical Trial Phase
Completed NCT02968433 - The Stanford Parkinson's Disease Plasma Study Phase 1
Recruiting NCT06245174 - A Smartphone Application for Neurology and Telemedicine
Completed NCT02656355 - Gait Initiation Difficulty and Anticipatory Postural Adjustment (APA) Impairment in People With PD - Evaluation and Training N/A
Completed NCT04193527 - A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients Phase 3
Completed NCT04748263 - Eye Gaze Strategies During Facial Emotion Recognition in Neurodegenerative Diseases: Links With Neuropsychiatric Disorders (EYE-ToM Study)
Recruiting NCT06367101 - AR Stimulation Effects on Gait, Anxiety, and Brain Connectivity in Parkinson's Disease N/A
Completed NCT01971528 - Central and Peripheral Fatigue in Individuals With Parkinson's Disease - Evaluation and Training N/A
Completed NCT05113524 - Effects of Dance on the Turning Characteristics of Patients With Parkinson's Disease N/A